Deepdive on Valuations:

- Valuation = Earnings x Earnings Multiplier (AKA PE)

- Choosing an Earnings Multiplier

- Thinking about Risk

- Risk in real estate vs in stocks

- Risk free rate

- Interest Rates are like gravity in the investing world

- Why Abi looks at the cap table/valuation first

- Using comparables to judge relative valuation

- Valuations of Canadian Companies vs US Companies

In this Market Update:

- Turmoil in the broader equity markets

- US 10 year treasury hits 1.6% - why that matters

- Flight to Safety (and out of Cannabis)

- Are we heading into a recession?

- Recessions vs Bear Markets

- What does that mean for businesses and investors?

- What does that mean for Cannabis Investing?

- How Big Cannabis Players can dominate in a recession

- Silver Lining: How Cannabis could outperform in a recession

- Catch us at the Benzinga Conference in Detroit this week!

- The fundamentals of investing in Cannabis companies

- Buying a company vs buying a stock

- Evaluating a company's valuation; why Abi reads the Cap Table FIRST

- Importance of patience and long term focus

- Risks involved in venture investing

- The art of a picking a winner

Next episode: Buy companies not stocks

PACKED market update including:

- Huge earnings from Aphria and why you should dig deeper into the revenue breakdown

- Strategic investments from Couche-Tard & Imperial Brands (for Fire & Flower and Auxly)

- Curaleaf's CVS deal gets pulled after FDA warning letter

- Is Manish buying or selling Curaleaf?

- More CannTrust drama

- Beyond Meat raising $650M USD and why it matters

- How Beyond Meat's business strategy relates to Cannabis

Next episode: How to invest in weed stocks 101

Has the market bottomed?

After a few brutal weeks we examine values in the market:

- What caused this recent drop in prices?

- What's the difference between a blip and a correction?

- How CannTrust caused the entire market to fall irrationally 

- What's next for CannTrust?

- Are market values attractive at these numbers?

- The strategy of buying companies around the problematic companies (like HomeTrust)

- Managing cash for situations like these

Market Update:

- Curaleaf buys Grassroots for ~$875M USD deal

- Neptune closes $41.5M USD raise

- Flower withdraws a $125M offering (indicates investor hesitation) (this was later turned into a $43M bought deal)

Activity:

- What Manish has done during this downturn

- The Origin House arbitrage opportunity

The intro episode! Welcome to the Cannabis Investing Network, a podcast created For Investors By Investors. Our focus is squarely on the public and private cannabis markets. 

In this episode:

- Manish's background in Commercial Real Estate

- Abi's background in Fixed Income

- How we both ended up investing in the Cannabis Space

- Our first ever investments and what we learned

- Is it too late to start investing in this space? Is all the easy money gone?

- Where the market is and where is it heading

- Canada vs US vs International focus

- Cultivation vs Extraction vs Brands

Next week's episode - Investing in Weed Companies 101

This mini-episode covers the state of the market as we currently see it (July 2019).

- CannTrust issues have pulled down the entire cannabis market

- Take a deep breath and remember investing is for the long-term

- Valuation = Earnings x Multiple; has other of these variables changed?

- Should you be adjusting your investment strategy?

- Why it is so important to research and understand the companies you buy into

- Market pullbacks mean your favourite companies are on sale

- Don't panic, act rationally and think long-term

Our first official episode "How to Invest in Weed Companies 101" coming soon!

- Manish & Abi

Comments, feedback, suggestions - [email protected]